Welcome to LookChem.com Sign In|Join Free
  • or
C-Benzo[d]isoxazol-3-yl-methylamine is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

155204-08-3

Post Buying Request

155204-08-3 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

155204-08-3 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 155204-08-3 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,5,5,2,0 and 4 respectively; the second part has 2 digits, 0 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 155204-08:
(8*1)+(7*5)+(6*5)+(5*2)+(4*0)+(3*4)+(2*0)+(1*8)=103
103 % 10 = 3
So 155204-08-3 is a valid CAS Registry Number.

155204-08-3SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 13, 2017

Revision Date: Aug 13, 2017

1.Identification

1.1 GHS Product identifier

Product name C-benzo[d]isoxazol-3-yl-methylamine

1.2 Other means of identification

Product number -
Other names 1,2-Benzisoxazole-3-methanamine

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:155204-08-3 SDS

155204-08-3Downstream Products

155204-08-3Relevant academic research and scientific papers

Amino sulfonyl compound, preparation method and uses thereof

-

Paragraph 0142; 0143; 0165, (2016/12/01)

The present invention relates to a new amino sulfonyl compound represented by a general formula I, or a tautomer, an enantiomer, a racemate or a pharmaceutically acceptable salt thereof, a preparation method, a pharmaceutical composition, and uses thereof, wherein the compound can be used for treatment of epilepsy, convulsion, obesity, and the like. The general formula I is defined in the specification.

Pyridine and Pyrazine derivative for the Treatment of CF

-

Page/Page column 39, (2011/10/10)

The present invention provides pyridine and pyrazine derivatives which restore or enhance the function of mutant and/or wild type CFTR to treat cystic fibrosis, primary ciliary dyskinesia, chronic bronchitis, chronic obstructive pulmonary disease, asthma, respiratory tract infections, lung carcinoma, xerostomia and keratoconjunctivitis sire, or constipation (IBS, IBD, opioid induced). Pharmaceutical compositions comprising such derivatives are also encompassed.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 155204-08-3